CIK 0001395937 · Large accelerated filer
Syndax Pharmaceuticals Inc
Sign in to watch- Ticker
- SNDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 320162505
- Phone
- 781-419-1400
- Business address
- 730 THIRD AVENUE, 9TH FLOOR, NEW YORK, NY, 10017
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $113,716
- in 1 filing, $114K under 10b5-1 plans
Net −$113,716. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-10-06 | Katkin Keith Director | Sale | −9,117 | $25.90 | $236K | 32,000 |
| 2022-10-06 | Katkin Keith Director | Option exercise · Stock Options (Right to buy) | −9,117 | 0 | ||
| 2022-10-06 | Katkin Keith Director | Option exercise · Stock Options (Right to buy) | −20,782 | 0 | ||
| 2022-10-06 | Metzger Michael A Chief Executive Officer | Option exercise | +16,231 | $8.77 | $142K | 33,890 |
| 2022-10-06 | Metzger Michael A Chief Executive Officer | Sale | −16,231 | $25.29 | $411K | 17,659 |
| 2022-10-06 | Metzger Michael A Chief Executive Officer | Option exercise · Stock Options (Right to buy) | −16,231 | 0 | ||
| 2022-10-04 | Metzger Michael A Chief Executive Officer | Option exercise | +1,280 | $8.77 | $11K | 18,939 |
| 2022-10-04 | Metzger Michael A Chief Executive Officer | Sale | −1,280 | $25.02 | $32K | 17,659 |
| 2022-10-04 | Metzger Michael A Chief Executive Officer | Option exercise · Stock Options (Right to buy) | −1,280 | 0 | ||
| 2022-10-04 | Katkin Keith Director | Option exercise | +137 | $7.88 | $1K | 32,137 |
| 2022-10-04 | Katkin Keith Director | Sale | −137 | $25.00 | $3K | 32,000 |
| 2022-10-04 | Katkin Keith Director | Option exercise | +223 | $8.93 | $2K | 32,223 |
| 2022-10-04 | Katkin Keith Director | Sale | −223 | $25.00 | $6K | 32,000 |
| 2022-10-04 | Katkin Keith Director | Option exercise · Stock Options (Right to buy) | −223 | 0 | ||
| 2022-10-04 | Katkin Keith Director | Option exercise · Stock Options (Right to buy) | −137 | 0 | ||
| 2022-10-03 | Metzger Michael A Chief Executive Officer | Option exercise | +2,883 | $8.77 | $25K | 20,542 |
| 2022-10-03 | Metzger Michael A Chief Executive Officer | Sale | −2,883 | $25.01 | $72K | 17,659 |
| 2022-10-03 | Metzger Michael A Chief Executive Officer | Option exercise · Stock Options (Right to buy) | −2,883 | 0 | ||
| 2022-10-03 | Katkin Keith Director | Option exercise | +167 | $7.88 | $1K | 32,167 |
| 2022-10-03 | Katkin Keith Director | Sale | −167 | $25.00 | $4K | 32,000 |
Page 10 of 15 · 290 trades